EDN1 and gout: No unified standard for the dosage of febuxostat in the treatment of hyperuricemia in previous studies, therefore, the present study was novel, which explores the effects of febuxostat in different doses on uric acid, inflammatory factors of serum and knee articular cavity, endothelin-1 and oxidative stress in patients with gout.